The purpose of this study is to investigate behavioral and other co-occurring outcomes with EPID(I/Y)OLEX as an add-on therapy in participants aged 1 to 65 years with tuberous sclerosis complex (TSC) who experience seizures.
- Investigator
- Hans Shuhaiber
- Ages
- 1 Year - 65 Years
- Sexes
- All